About Avansdose
Avansdose is a company based in Ankleshwar (India) founded in 2020. It operates as a B2B. Avansdose offers products and services including Oncology API and Synthesis Peptides. Avansdose operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Ankleshwar, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Avansdose Pharmatech Private Limited
- Date of Incorporation 27 Feb, 2017
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$1.52 M (USD)18.34as on Mar 31, 2023
-
Net Profit
$15.8 K (USD)39.71as on Mar 31, 2023
-
EBITDA
$21.35 K (USD)-28.84as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Avansdose
Avansdose offers a comprehensive portfolio of products and services, including Oncology API and Synthesis Peptides.
Produces high-quality APIs for oncology drugs and treatments.
Develops peptides for various therapeutic categories.
Funding Insights of Avansdose
Detailed funding history for Avansdose
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avansdose
Investment portfolio details for Avansdose
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Avansdose
Detailed financials for Avansdose
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avansdose Comparisons
Peer comparison for Avansdose
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Avansdose
Avansdose operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Avansdose
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avansdose
Complete news archive for Avansdose
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avansdose
Avansdose was founded in 2020.
Avansdose is headquartered in Ankleshwar, India. It is registered at Ankleshwar, Gujarat, India.
Annual revenue of Avansdose is $1.52M as on Mar 31, 2023.
AvansDose specializes in manufacturing high-quality oncology APIs, emphasizing cost-effectiveness and adherence to Good Manufacturing Practices. They operate RD facilities focused on oncology products and expanding to peptides. Located in Hyderabad, India, they ensure compliance with environmental and safety regulations while supplying APIs for life-saving drugs to global clients.
Avansdose's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Avansdose offers Oncology API and Synthesis Peptides.